treatment options

  • December 4, 2020 

    What Is a Cancer Commons Options Report?

    With: Lola Rahib, PhD

    As a Cancer Commons Scientist, Lola Rahib, PhD, helps cancer patients and caregivers navigate treatment. Some of these patients receive a Cancer Commons Options Report. Here, our Curious Dr. George asks Dr. Rahib to share what goes into each Options… Read more »

  • August 18, 2020 

    Tumor Boards—What Are They and How Can They Help You?

    Julie Friedland, PhD

    One of the most powerful tools in cancer treatment today is the tumor board—a group of cancer experts who delve into individual cancer patients’ cases to help them explore their treatment options. As our world increasingly shifts online, virtual tumor… Read more »

  • August 9, 2019 

    All About Pancreatic Cancer, for Patients and CaregiversBookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD:

    The National Cancer Institute has put together this useful guide to pancreatic cancer for patients and caregivers. (Click here for a different version for health professionals.)

  • August 9, 2019 

    All About Pancreatic Cancer, for Cancer ProfessionalsBookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD:

    The National Cancer Institute has put together this useful guide to pancreatic cancer, aimed for an audience of oncology professionals. (Click here for the patient-oriented version.)

  • August 5, 2019 

    Navigating Pancreatic Cancer—The Basics

    With: Lola Rahib, PhD

    A Q&A with Lola Rahib, PhD, Lead Scientist, Pancreas Cancer, at Cancer Commons, Los Altos, CA; lola.rahib@cancercommons.org Q: Navigating a pancreatic cancer diagnosis can be overwhelming and confusing for patients and their loved ones. How can patients and their caregivers… Read more »

  • March 9, 2018 

    A New Regulatory Threat to Cancer PatientsBookmark

    Emma Shtivelman, PhD

    Excerpt:

    “The federal government is threatening to limit treatment options for doctors fighting cancer. A regulatory decision due Wednesday from the Centers for Medicare and Medicaid Services could undermine the care delivered to the more than 1.6 million Americans who are diagnosed with cancer each year.”

    Go to full article published by The Wall Street Journal on Feb 25, 2018.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.